期刊
UROLOGIC CLINICS OF NORTH AMERICA
卷 27, 期 1, 页码 147-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/S0094-0143(05)70242-1
关键词
-
Despite incomplete understanding of the human immune system, the rapid progress in tumor immunology provides a framework for effective and safe interventions in the near future. Early approaches in patients with cancer that have focused on the nonspecific and broad stimulation of the immune system by interferons and IL-12 will be replaced by the highly specific stimulation of immune reactions targeting precisely defined tumor antigens. IL-12 has several biologic properties that seem useful in immune therapy fur bladder cancer. The striking antitumor responses with IL-12 in preclinical animal models of bladder cancer provide optimism that future clinical trials involving this agent may impact on the risk and mortality associated with this disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据